iopamidol has been researched along with Active Hyperemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cerrato, E; Conrotto, F; D'Ascenzo, F; Echavarria-Pinto, M; Escaned, J; Macaya, F; Pavani, M; Quadri, G; QuirĂ³s, A; Salinas, P; Tomassini, F; Varbella, F | 1 |
Aurigemma, C; Basile, E; Burzotta, F; Cialdella, P; Clemente, F; Crea, F; De Caterina, AR; De Maria, GL; Gardi, A; Leone, AM; Niccoli, G; Porto, I; Rebuzzi, AG; Scalone, G; Tagliaferro, F; Trani, C | 1 |
2 other study(ies) available for iopamidol and Active Hyperemia
Article | Year |
---|---|
Simplified hybrid algorithms for pressure wire interrogation exploiting advantages of a baseline and contrast Pd/Pa ratio indexes to predict stenosis significance: Insight from the SPARE multicenter prospective study.
Topics: Adenosine; Aged; Algorithms; Cardiac Catheterization; Cardiac Catheters; Clinical Decision-Making; Contrast Media; Coronary Angiography; Coronary Stenosis; Europe; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Iopamidol; Male; Middle Aged; Patient Selection; Percutaneous Coronary Intervention; Predictive Value of Tests; Prognosis; Prospective Studies; Severity of Illness Index; Signal Processing, Computer-Assisted; Transducers, Pressure; Vasodilator Agents | 2018 |
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study.
Topics: Adenosine; Aged; Area Under Curve; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Injections, Intra-Arterial; Iopamidol; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; ROC Curve; Severity of Illness Index; Vasodilator Agents | 2015 |